06:36 EDT Sage Therapeutics files automatic mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SAGE:
- Sage Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP for More Information – SAGE
- Sage Therapeutics price target lowered to $13 from $18 at Truist
- Closing Bell Movers: Dutch Bros melts over 20% on slower unit growth
- Sage Therapeutics price target lowered to $9 from $17 at Canaccord
- Sage Therapeutics reports Q2 EPS ($1.70), consensus ($1.66)